Range
111.41 - 118.17
Vol / Avg.
160.3K/169.3K
Div / Yield
-
52 Wk
69.58 - 146.97
Mkt Cap
3.3B
Payout Ratio
-
Open
118.17
P/E
-
EPS
-1.1
Shares
29.5M
Outstanding
29.5M
Total Float
22.7M
load more
Sector: Health Care.Industry: Biotechnology
Karuna Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-1.380-1.100 0.2800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KRTXKaruna Therapeutics-3.84%3.3B

Karuna Therapeutics Frequently Asked Questions

Q

How do I buy Karuna Therapeutics (KRTX) stock?

A

You can purchase shares of Karuna Therapeutics (NASDAQ: KRTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Karuna Therapeutics's (KRTX) competitors?

Q

What is the target price for Karuna Therapeutics (KRTX) stock?

A

The latest price target for Karuna Therapeutics (NASDAQ: KRTX) was reported by RBC Capital on June 23, 2021. The analyst firm set a price target for 173.00 expecting KRTX to rise to within 12 months (a possible 52.68% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Karuna Therapeutics (KRTX)?

A

The stock price for Karuna Therapeutics (NASDAQ: KRTX) is $113.31 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Karuna Therapeutics (KRTX) pay a dividend?

A

There are no upcoming dividends for Karuna Therapeutics.

Q

When is Karuna Therapeutics (NASDAQ:KRTX) reporting earnings?

A
Karuna Therapeutics’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Karuna Therapeutics (KRTX) going to split?

A

There is no upcoming split for Karuna Therapeutics.

Q

What sector and industry does Karuna Therapeutics (KRTX) operate in?

A

Karuna Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.